Skip to main content
Clinical Trials/CTRI/2024/06/069376
CTRI/2024/06/069376
Not yet recruiting
Phase 4

Effect of antenatal Dexamethasone therapy on maternal blood glucose levels and fetal well being - NI

Government medical college and hospital0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: O429- Premature rupture of membranes, unspecified as to length of time between rupture and onset of labor
Sponsor
Government medical college and hospital
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Government medical college and hospital

Eligibility Criteria

Inclusion Criteria

  • 1 Pregnant women between 26\-34 weeks of gestation with threatened preterm labor pains and premature rupture of membranes
  • 2 Antenatal women between 34\-39 weeks planned for lower segment cesarean section (LSCS)

Exclusion Criteria

  • 1\) Pregnant women with pre\-existing diabetes and gestational diabetes mellitus.
  • 2\) Pregnant women with fetal growth restriction.
  • 3\) Patients who require immediate termination of pregnancy or are in established preterm labor.
  • 4\) Pregnant women with evidence of infection, where corticosteroid therapy may lead to flare\-up of infection.
  • 5\) Patients with chronic kidney disease, and pre\-existing adrenal and pancreatic dysfunction.
  • 6\) Pregnant women who have received tocolysis with beta\-mimetic agents.
  • 7\) Multifetal gestation.

Outcomes

Primary Outcomes

Not specified

Similar Trials